Showing results (281-290 of 1,242) with videos related to
Sort By:
Pageof 125
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 13, 2026
Cognitive and behavioral involvement in spinal and bulbar muscular atrophy (SBMA): a systematic reviewGiulia De Luca, Edoardo Nicolò Aiello, Arianna Moreschi, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 5, 2026
Bridging the gap: understanding participation barriers in ALS clinical trials through on-the-ground insightsErica Scirocco, Allison Pogemiller Bulat, Judith R Carey, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 23, 2023
Non-motor symptoms in amyotrophic lateral sclerosis: lessons from Parkinson's diseaseAli Shojaie, Silvia Rota, Ahmad Al Khleifat, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 30, 2023
PROSA-a multicenter prospective observational study to develop low-burden digital speech biomarkers in ALS and FTDJohannes Tröger, Judith Baltes, Ebru Baykara, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 9, 2023
Single task-level, 2SD-based cutoffs for the Italian version of the Edinburgh Cognitive and Behavioral ALS screen (ECAS)Barbara Poletti, Edoardo Nicolò Aiello, Antonino La Tona, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 25, 2026
Opportunities and challenges related to participant stratification and cohort enrichment in ALS clinical trialsSabrina Yusuf, Matti D Allen, HyungMo Kang, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 18, 2016
Prognostic factors and survival of ALS patients from Belgrade, SerbiaZorica Stevic, Svetlana Kostic-Dedic, Stojan Peric, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 21, 2017
A retrospective investigation of the relationship between baseline covariates and rate of ALSFRS-R decline in ALS clinical trialsIyas Daghlas, Teresa E Lever, Emily LearyAmyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 29, 2015
A further Rasch study confirms that ALSFRS-R does not conform to fundamental measurement requirementsFranco Franchignoni, Jessica Mandrioli, Andrea Giordano, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 15, 2026
Innate immune signaling as a potential pathomechanistic biomarker for distinct subtypes in amyotrophic lateral sclerosisMarcel Naumann, Stefanie Kretschmer, Johannes Dorst, et al.Pageof 125